Tower Research Capital LLC (TRC) - ATOSSA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,753
-53.9%
13,233
-21.2%
0.00%
-100.0%
Q2 2023$21,148
+264250.0%
16,784
+61.4%
0.00%
Q1 2023$8
+300.0%
10,400
+196.2%
0.00%
Q4 2022$23,511
+8065.1%
0.00%
Q3 2022$0
-100.0%
43
-96.8%
0.00%
Q2 2022$1,000
-96.9%
1,351
-94.7%
0.00%
Q1 2022$32,000
-11.1%
25,391
+13.6%
0.00%
-100.0%
Q4 2021$36,000
+50.0%
22,360
+195.6%
0.00%0.0%
Q3 2021$24,000
-20.0%
7,564
+58.0%
0.00%0.0%
Q2 2021$30,000
+900.0%
4,787
+292.4%
0.00%
Q3 2020$3,000
-50.0%
1,220
-27.2%
0.00%
Q2 2020$6,0000.0%1,676
-25.5%
0.00%
Q2 2019$6,0002,2500.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 242,237$511,0000.10%
CVI Holdings, LLC 432,305$912,0000.06%
Virtu Financial LLC 271,937$574,0000.04%
XTX Topco Ltd 20,392$43,0000.02%
Newbridge Financial Services Group, Inc. 7,000$15,0000.01%
Renaissance Technologies 3,304,140$6,972,0000.01%
GSA CAPITAL PARTNERS LLP 22,925$48,0000.01%
Bienville Capital Management, LLC 28,379$60,0000.01%
Cutler Group LLC / CA 223,100$116,0000.01%
Royal Fund Management, LLC 15,000$31,0000.01%
View complete list of ATOSSA THERAPEUTICS INC shareholders